Swiss National Bank’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-81,500
| Closed | -$630K | – | 2442 |
|
|
2024
Q4 | $630K | Hold |
81,500
| – | – | ﹤0.01% | 2357 |
|
|
2024
Q3 | $855K | Hold |
81,500
| – | – | ﹤0.01% | 2282 |
|
|
2024
Q2 | $954K | Hold |
81,500
| – | – | ﹤0.01% | 2194 |
|
|
2024
Q1 | $1.72M | Buy |
81,500
+3,500
| +4% | +$62.3K | ﹤0.01% | 1923 |
|
|
2023
Q4 | $1.4M | Sell |
78,000
-8,000
| -9% | -$141K | ﹤0.01% | 2054 |
|
|
2023
Q3 | $1.42M | Buy |
86,000
+5,500
| +7% | +$99.7K | ﹤0.01% | 2052 |
|
|
2023
Q2 | $1.61M | Buy |
80,500
+1,100
| +1% | +$21.2K | ﹤0.01% | 2031 |
|
|
2023
Q1 | $1.5M | Sell |
79,400
-9,300
| -10% | -$206K | ﹤0.01% | 2020 |
|
|
2022
Q4 | $2.01M | Buy |
88,700
+1,800
| +2% | +$40.7K | ﹤0.01% | 1890 |
|
|
2022
Q3 | $2.3M | Buy |
86,900
+1,300
| +2% | +$38.6K | ﹤0.01% | 1773 |
|
|
2022
Q2 | $2.11M | Buy |
85,600
+9,700
| +13% | +$242K | ﹤0.01% | 1873 |
|
|
2022
Q1 | $2.52M | Buy |
75,900
+5,400
| +8% | +$150K | ﹤0.01% | 1902 |
|
|
2021
Q4 | $2.31M | Hold |
70,500
| – | – | ﹤0.01% | 1960 |
|
|
2021
Q3 | $2.96M | Buy |
70,500
+600
| +0.9% | +$21.6K | ﹤0.01% | 1794 |
|
|
2021
Q2 | $2.72M | Sell |
69,900
-15,800
| -18% | -$565K | ﹤0.01% | 1901 |
|
|
2021
Q1 | $2.92M | Buy |
85,700
+14,000
| +20% | +$597K | ﹤0.01% | 1779 |
|
|
2020
Q4 | $3.25M | Hold |
71,700
| – | – | ﹤0.01% | 1628 |
|
|
2020
Q3 | $1.97M | Buy |
71,700
+1,200
| +2% | +$39.1K | ﹤0.01% | 1723 |
|
|
2020
Q2 | $2.6M | Buy |
70,500
+6,100
| +9% | +$227K | ﹤0.01% | 1561 |
|
|
2020
Q1 | $2.08M | Buy |
64,400
+1,000
| +2% | +$41.7K | ﹤0.01% | 1434 |
|
|
2019
Q4 | $2.6M | Buy |
63,400
+1,600
| +3% | +$63.2K | ﹤0.01% | 1567 |
|
|
2019
Q3 | $2.2M | Buy |
61,800
+900
| +1% | +$36.5K | ﹤0.01% | 1607 |
|
|
2019
Q2 | $3.13M | Buy |
60,900
+2,100
| +4% | +$105K | ﹤0.01% | 1418 |
|
|
2019
Q1 | $3.37M | Buy |
58,800
+3,100
| +6% | +$154K | ﹤0.01% | 1336 |
|
|
2018
Q4 | $2.34M | Buy |
55,700
+5,600
| +11% | +$329K | ﹤0.01% | 1461 |
|
|
2018
Q3 | $3.78M | Buy |
50,100
+1,300
| +3% | +$93.7K | ﹤0.01% | 1301 |
|
|
2018
Q2 | $3.5M | Buy |
48,800
+2,900
| +6% | +$138K | ﹤0.01% | 1329 |
|
|
2018
Q1 | $1.37M | Buy |
45,900
+3,300
| +8% | +$96K | ﹤0.01% | 1890 |
|
|
2017
Q4 | $1.42M | Hold |
42,600
| – | – | ﹤0.01% | 1869 |
|
|
2017
Q3 | $1.4M | Hold |
42,600
| – | – | ﹤0.01% | 1848 |
|
|
2017
Q2 | $841K | Hold |
42,600
| – | – | ﹤0.01% | 2159 |
|
|
2017
Q1 | $822K | Buy |
42,600
+10,000
| +31% | +$193K | ﹤0.01% | 2145 |
|
|
2016
Q4 | $605K | Buy |
+32,600
| New | +$623K | ﹤0.01% | 2310 |
|
Other funds holding RGNX
RG
Swiss National Bank's RGNX Position: Q1 2025 in Review
Swiss National Bank sold out of Regenxbio (RGNX) in Q1 2025, closing a stake of 81,500 shares — an estimated $630K sold.
Swiss National Bank first reported a position in RGNX in Q4 2016 and held it in 33 quarters. The position peaked at $3.78M in Q3 2018. 164 funds tracked by Wall St. Rank hold RGNX as of Q1 2025.
- Swiss National Bank reported no remaining Regenxbio position as of Q1 2025 after selling out during the quarter.
- Swiss National Bank sold 81,500 Regenxbio shares in Q1 2025, an estimated $630K.
- Swiss National Bank first reported a position in Regenxbio in Q4 2016 and held it in 33 quarters.
- Swiss National Bank's Regenxbio position peaked at $3.78M in Q3 2018.
- 164 funds tracked by Wall St. Rank held Regenxbio as of Q1 2025.
Based on Swiss National Bank's 13F filing for Q1 2025, filed 12 May 2025.